image
Aldeyra Therapeutics, Inc. ALDX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.21
-1.41 %
$ 251 M
Market Cap
-5.61
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-42.8 M OPERATING INCOME
31.73%
Growth Rates
1Year 31.73%
3Years -5.52%
5Years -1.51%
7Years -12.56%
10Years -27.82%
-37.5 M NET INCOME
39.47%
Growth Rates
1Year 39.47%
3Years 0.01%
5Years 0.70%
7Years -10.47%
10Years -14.50%
EFFICIENCY
Earnings Waterfall Aldeyra Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 263 K
Gross Profit -263 K
Operating Expenses 42.8 M
Operating Income -42.8 M
Other Expenses -5.25 M
Net Income -37.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0.3 0.3 0.3 56.2 K 96.3 K 71 K 37.8 K 35.8 K 18.8 K 0 0 0 0
Gross Profit (0.3) (0.3) (0.3) 56.2 K 96.3 K 71 K 37.8 K 35.8 K 18.8 K 0 0 0 0
OPERATING INCOME
Operating Expenses 42.8 62.7 56.2 34.7 56.5 39.7 22.5 18.7 12.0 7.3 3.7 1.1 2.1
Selling, General and Administrative Expenses 13.3 15.4 11.3 10.0 12.2 9.9 6.2 5.5 4.4 3.6 2.1 0.6 0.7
Research and Development Expenses 29.5 47.3 44.9 24.7 44.4 29.8 16.3 13.2 7.6 3.7 1.5 0.5 1.4
Operating Income (42.8) (62.7) (56.2) (36.4) (63.1) (39.7) (22.5) (18.7) (12.0) (7.3) (3.7) (1.1) (2.1)
PRE-TAX INCOME
Interest Income Expense 2.1 1.7 1.7 1.9 0.6 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3
Total Other Income 5.3 0.7 (1.6) (3.4) (5.6) 0.8 0.1 3.47 K (0.1) 2.1 16.7 (22.0) (0.3)
Pre-Tax Income (37.5) (62.0) (57.8) (38.0) (62.1) (38.9) (22.3) (18.7) (12.1) (5.2) 13.1 (23.1) (2.4)
NET INCOME
Tax Provision 0 (0.7) 1.5 (0.5) (1.3) 1.0 0.2 66.2 K 7.65 K 0.2 0.2 (21.1) 0.3
Net Income (37.5) (61.4) (59.3) (37.6) (60.8) (38.9) (22.3) (18.7) (12.1) (5.2) 13.1 (23.1) (2.4)
EPS 0.64 1.05 1.1 1.11 2.24 1.79 1.4 1.65 1.4 1.36 39.9 5.72 7.26